首頁 > 市場調查報告書 > 製藥

感染疾病

達菲市場：按藥物類型、配方、適應症（甲型流感、乙型流感、豬流感）、分銷渠道、地區-規模、份額、展望、機會分析，2022-2030 年

市場調查報告書

商品編碼

1213870

達菲市場：按藥物類型、配方、適應症（甲型流感、乙型流感、豬流感）、分銷渠道、地區-規模、份額、展望、機會分析，2022-2030 年

Tamiflu Market, by Drug Type, by Dosage Form, by Indication (Influenza A, Influenza B, and Swine Flu ), by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2023年01月18日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

磷酸奧司他韋適用於甲型流感、乙型流感等。它可以減輕流感病毒引起的症狀，例如鼻塞、咳嗽、喉嚨痛、發燒/發冷、疼痛和不適。此外，該藥物可將恢復時間縮短 1 至 2 天。如果您與其他流感患者有過接觸，或者您所在地區正在流行流感，則該藥物也可用於預防流感。該藥物的作用機制是阻止流感病毒繁殖。應按照醫生規定的適當時間間隔服用藥物。如果提前停藥，可能會導致病毒繁殖和感染復發。

市場動態

美國不斷上升的流感發病率預計將在預測期內推動全球達菲（磷酸奧司他韋）市場的增長。例如，根據發表在《柳葉刀》雜誌上的一篇論文，到 2022 年，症狀性流感的年發病率估計為 3-11%。美國國家免疫和呼吸系統疾病中心的研究人員進行的多項研究表明，兒童最容易感染流感病毒並患病，而且發病率隨著年齡的增長而降低。

達菲（磷酸奧司他韋）的投放量預計會增加，從而在預測期內推動全球達菲（磷酸奧司他韋）的增長。例如，2018 年，印度製藥公司 Natco Pharma 及其營銷合作夥伴美國製藥公司 Alvogen 在美國推出了第一個仿製藥 Tamiflu（磷酸奧司他韋）。

這項研究的主要特點

本報告對全球達菲（磷酸奧司他韋）市場進行了深入分析，顯示了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。優惠。
它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
它還提供重要的見解，例如市場促進因素、抑制因素、機會、新產品發佈或批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
它根據以下參數介紹了全球達菲（磷酸奧司他韋）市場的主要參與者 - 公司亮點、產品組合、主要亮點、財務業績、本研究涵蓋的戰略 F.Hoffmann-La Roche Ltd. 、NATCO Pharma Limited、Tea Pharmaceutical Industries Ltd.、LUPINE Limited、Amneal Pharmaceuticals LLC、Zydus Cadila、Sun Pharmaceutical Industries Ltd.、Alembic Pharmaceuticals Limited、Mylan N.V. 和 Hetero Group。
這份報告中的見解將使企業營銷人員和管理人員能夠就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。
本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球達菲（磷酸奧司他韋）市場的各種戰略矩陣來促進他們的決策。

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲地區
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第 10 章競爭格局

F.Hoffmann-La Roche Ltd.
NATCO Pharma Limited
Teva Pharmaceutical Industries Ltd.
LUPIN Limited
Amneal Pharmaceuticals LLC
Zydus Cadila
Sun Pharmaceutical Industries Ltd.
Alembic Pharmaceuticals Limited
Mylan N.V
Hetero Group

第 11 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5489

Oseltamivir phosphate is indicated for the treatment of influenza A, influenza B, and Others. It reduces the symptoms caused by influenza virus such as stuffy nose, cough, sore throat, fever/chills, aches, and tiredness. Moreover, the medicine reduces the recovery time by 1-2 days. This medication may also be used to prevent the flu if the person is exposed to other patient who already is suffering from flu or if there is a flu pandemic in the community. The mode of action for the treatment is that, this medication works by stopping the flu virus from growing. The medicine should be taken at the proper time interval as prescribed by the doctor. If the intake of medicine is terminated at an early stage then, this may lead to the growth of the virus, which may relapse of the infection.

Market Dynamics

Increasing incidence of influenza among the U.S. population is expected to increase the growth of the global Tamiflu (oseltamivir phosphate) market over the forecast period. For instance, according to the article published in the Lancet journal, 2022, the annual incidence of symptomatic influenza is estimated to vary from 3 to 11%. According to the various studies carried out by the researchers in National Center for Immunization and Respiratory Diseases, U.S., it was found that, influenza virus infections and illness rates are highest in children and the rate of illness decrease with the increasing age.

Increasing launches of Tamiflu (oseltamivir phosphate) is expected to drive the growth of the global Tamiflu (oseltamivir phosphate) over the forecast period. For instance, in 2018, Natco Pharma, Indian pharmaceutical company and their marketing partner Alvogen, U.S. based pharmaceutical company launched, the first generic version of Tamiflu (oseltamivir phosphate) in the U.S.

Key features of the study:

This report provides in-depth analysis of the global Tamiflu (oseltamivir phosphate) market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Tamiflu (oseltamivir phosphate) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd., NATCO Pharma Limited, Tea Pharmaceutical Industries Ltd., LUPIN Limited, Amneal Pharmaceuticals LLC, Zydus Cadila, Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, Mylan N.V., and Hetero Group.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Tamiflu (oseltamivir phosphate) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Tamiflu (oseltamivir phosphate) market

Detailed Segmentation:

Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type:
- Branded
- Generic
Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form:
- Capsules
- Suspension
Global Tamiflu (Oseltamivir Phosphate) Market By Indication:
- Influenza A
- Influenza B
- Swine Flu (H1N1 Influenza A)
Global Tamiflu (Oseltamivir Phosphate) Market By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Tamiflu (Oseltamivir Phosphate) Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- F. Hoffmann-La Roche Ltd.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- NATCO Pharma Limited
- Teva Pharmaceutical Industries Ltd.
- LUPIN Limited
- Amneal Pharmaceuticals LLC
- Zydus Cadila
- Sun Pharmaceutical Industries Ltd.
- Alembic Pharmaceuticals Limited
- Mylan N.V.
- Hetero Group

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Market Trends
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
Pricing Analysis (2021)

4. Global Tamiflu (Oseltamivir Phosphate) Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Tamiflu (Oseltamivir Phosphate) Market, By Indication, 2017 - 2030, (US$ Million

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Influenza A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Influenza B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Swine Flu (H1N1 Influenza A)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Tamiflu (Oseltamivir Phosphate) Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Tamiflu (Oseltamivir Phosphate) Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

10. Competitive Landscape

F.Hoffmann-La Roche Ltd.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NATCO Pharma Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LUPIN Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amneal Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alembic Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hetero Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies